Price Alert

Galmed Pharmaceuticals Lt... (GLMD)

NASDAQ: GLMD · Real-Time Price · USD

1.43

-0.05 (-3.38%)

At close: Aug 15, 2025, 3:59 PM

1.47

3.14%

After-hours: Aug 15, 2025, 07:58 PM EDT

Galmed Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	4.77M	4.65M	9.72M	1.84M	1.58M	2.98M	1.48M	1.01M	1.67M	2.02M	4.06M	1.98M	3.74M	2.88M	3.49M	7.92M	13.38M
Short-Term Investments	10.96M	10.68M	7.42M	7.99M	9.35M	9.78M	11.83M	8.32M	10.48M	11.77M	15.15M	20.42M	25M	31.93M	38.41M	43.14M	45.42M
Long-Term Investments	2.12M	2.12M	3.27M	3.27M	3.27M	3.27M	3.27M	3.27M	1.68M	1.5M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	267K	257K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Receivables	447K	209K	426K	135K	254K	165K	770K	341K	568K	n/a	1.15M	614K	843K	79K	1.67M	487K	784K
Inventory	n/a	n/a	n/a	n/a	-371K	n/a	-1.81M	114.54K	113.32K	114K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	122K	121K	119K	118K	n/a	n/a	115K	456.00	682.00	n/a	114K	114K	114K	114K	113K	113K	113K
Total Current Assets	16.3M	16.12M	17.68M	10.08M	11.18M	13.24M	14.2M	9.79M	12.83M	14.72M	20.48M	23.13M	29.7M	36.05M	43.69M	51.66M	59.7M
Property-Plant & Equipment	n/a	n/a	n/a	n/a	74K	125K	175K	226K	281K	337K	391K	445K	497K	551K	606K	660K	675K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	2.39M	2.38M	3.27M	3.27M	3.34M	3.39M	3.44M	3.49M	1.96M	1.84M	391K	445K	497K	551K	606K	660K	675K
Total Assets	18.68M	18.5M	20.95M	13.34M	14.52M	16.63M	17.64M	13.28M	14.79M	16.56M	20.87M	23.57M	30.2M	36.6M	44.3M	52.33M	60.38M
Account Payables	1.31M	1.31M	1.34M	1.2M	1.38M	1.88M	1.47M	2.14M	2.27M	2.56M	4.75M	2.09M	4.83M	4.87M	5.23M	5.63M	5.8M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-171K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	n/a	603K	n/a	351K	382K	n/a	617K	583K	535K	363K	282K	640K	812K	1.01M	1.11M	1.38M	1.33M
Total Current Liabilities	1.81M	2.17M	2.51M	1.55M	1.76M	2.75M	2.09M	2.72M	2.8M	3.09M	5.03M	2.73M	5.65M	5.88M	6.35M	7.01M	7.14M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.27M	44K	89K	134K	183K	229K	274K	318K	283K
Total Liabilities	1.81M	2.17M	2.51M	1.55M	1.76M	2.75M	2.09M	2.72M	2.8M	3.14M	5.12M	2.86M	5.83M	6.11M	6.62M	7.33M	7.42M
Total Debt	n/a	n/a	n/a	n/a	n/a	41K	n/a	n/a	n/a	44K	89K	134K	183K	229K	274K	318K	283K
Common Stock	1.03M	742K	665K	263K	249K	209K	166K	70K	70K	70K	70K	70K	70K	70K	70K	70K	70K
Retained Earnings	-201.57M	-200.47M	-197.26M	-195.35M	-194.23M	-192.95M	-190.94M	-189.46M	-187.87M	-186.04M	-183.4M	-178.05M	-174.32M	-168.17M	-160.72M	-153.01M	-144.61M
Comprehensive Income	-397K	-416K	-342K	-435K	-455K	-454K	-607K	-662K	-645K	-745K	-876K	-982K	-616K	-171K	-75K	108K	142K
Shareholders Equity	16.88M	16.33M	18.44M	11.79M	12.76M	13.88M	15.55M	10.55M	11.99M	13.42M	15.75M	20.71M	24.37M	30.5M	37.68M	45M	52.96M
Total Investments	13.08M	12.8M	10.68M	11.25M	12.61M	13.05M	15.1M	11.59M	12.16M	13.27M	15.15M	20.42M	25M	31.93M	38.41M	43.14M	45.42M